Table 2 of Zeng, Mol Vis 2013; 19:729-736.

Table 2. The serum levels of MMPs and TIMPs in the four groups (ng/ml)

Serum factors
(Mean ± SD) early AMD (n=75) nAMD (n=89) PCV (n=98) Control (n=80)
MMP1 631.7±352.4* 643.7±441.9* 694.6±518.9* 658.3±389.5
MMP2 47.6±12.6* 50.9±14.7* 56.9±11.1† 49.0±10.8
MMP3 15.1±7.9* 16.1±17.2* 18.2±17.3* 17.9±18.8
MMP9 388.0±199.4* 579.6±353.9* 801.4±424.7‡ 420.7±162.0
TIMP1 190.2±189.5* 209.7±247.8* 215.9±218.9* 195.8±218.6
TIMP3 39.3±18.7* 42.0±16.2* 40.2±25.4* 36.7±19.5

Abbreviations: MMP=Matrix metalloproteinases; TIMP=Tissue metalloproteinase inhibitors; AMD=Age-related macular degeneration; nAMD=neovascular Age-related macular degeneration; PCV=Polypoidal choroidal vasculopathy; SD=standard deviation compared with control: * p>0.05; † p<0.05; ‡ p<0.001

Zeng, Mol Vis 2013; 19:729-736. http://www.molvis.org/molvis/v19/729

©2013 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535